Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
33.25
+1.36 (4.26%)
Apr 22, 2025, 12:31 PM EDT - Market open
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $233.66 million as of April 22, 2025. Its market cap has increased by 2,656.76% in one year.
Market Cap
233.66M
Enterprise Value
191.86M
1-Year Change
2,656.76%
Ranking
Category
Stock Price
$33.25
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $233.66M, an increase of 459.23%. That is a compound annual growth rate of 50.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 233.66M | -6.77% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |